| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Results of the phase Ib dose escalation study of MEN1611, a PI3K inhibitor, combined with trastuzumab (T) +/- fulvestrant (F) for HER2+/PIK3CA mutant (mut) advanced or metastatic (a/m) breast cancer (BC) |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | Piccart M., M. Borrego R, Duhoux F., Arkenau H-T., B. de Speville D, Wildiers H., Campone M., Tosi D., Garcia-Corbacho J., Jimenez B., S. de Romani E-, Wardley A.M, Tassone P., Boni V., Jerez Y., Aftimos P.G, Hennequin A., Amair-Pinedo F., Pellacani A.UE, Laurent D.O |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 31 |
| Pagination | S386 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1016/j.annonc.2020.08.449 |
